News Headlines Article

UnitedHealth sets sail for drug manager Catamaran
USA Today

UnitedHealth Group (UNH), the nation’s largest medical insurer, plans to buy drug benefits manager Catamaran (CTRX) in an effort to contain pharmaceutical drug prices.

The deal, valued at nearly $13 billion ($61.50 a share), is designed to help the insurer seek better prices with pharmaceutical companies and drug stores.

Catamaran jumped 25% to $60.20 in early trading Monday. UnitedHealth is up 4% to $122.92.